This course covers the learning objectives of screening for osteoporosis, identifying clinical risk factors, understanding low impact fractures, evaluating secondary osteoporosis, and assessing fracture risk using tools like FRAX. It also teaches about available osteoporosis medications, treatment failure considerations, subtrochanteric fractures, the impact of bisphosphonates on bone turnover, and the effects of Denosumab on bone density and fracture risk. The teaching method includes lectures and case studies. The intended audience for this course is healthcare professionals, particularly those in the fields of endocrinology, orthopedics, and internal medicine.
Overview
Syllabus
Intro
Learning objectives
When to screen for osteoporosis?
Clinical risk factors
Low impact fractures and osteoporosis
Following a hip fracture...
Causes of bone loss to be considered in the workup of osteoporosis
Evaluation for secondary osteoporosis
Fracture risk in patients with osteopenia FRAX
Available osteoporosis medications
Fracture protection seen even in patients who lose bone on treatment
What is considered treatment failure?
It depends on why the treatment failed...
Subtrochanteric fractures Definition
Why do they happen with BP? Let's review bone turnover
Risk of SF decreases after stopping bisphosphonates
Can we stop bisphosphonates? FLEX trial
Effect of Denosumab on bone density
Effect of Denosumab on fracture
Safety concerns
Taught by
Mary Greeley Medical Center
